Serplulimab for Locally Advanced Cervical Cancer

Clinical trial NCT07340489 · RECRUITING

Trial details

NCT number: NCT07340489
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Cancer

Start date: 2025-12-03
Primary completion: 2027-11-30
Enrollment: 216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.